On Our Radar

Aptinyx, Inc. was forced to suspend its study of NYX-458—a treatment for cognitive impairment in…

By identifying potential genetic causes of Lewy body dementia (LBD), researchers hope to gain a…

Although some symptoms of Parkinson’s disease (PD) can be controlled by medication, the hope of…

Alterity Therapeutics announced that it has received a second grant from The Michael J. Fox…

Parkinson’s is a complicated neurological disorder that researchers are continuously working to understand. However, a…

MODAG, a German biotechnology company, announced that it would begin an in-patient clinical trial of anle138b,…

The two companies announced an exclusive collaboration agreement that aims to develop treatments that target…

Good news in the world of drug development and future treatments for synucleinopathies...

A group of international experts responded to the publication of the recent Systemic Synuclein Sampling…